Rizos H - Search Results

1

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma.

Carlino MS, Gowrishankar K, Saunders CA, Pupo GM, Snoyman S, Zhang XD, Saw R, Becker TM, Kefford RF, Long GV, Rizos H. Carlino MS, et al. Among authors: rizos h. Mol Cancer Ther. 2013 Jul;12(7):1332-42. doi: 10.1158/1535-7163.MCT-13-0011. Epub 2013 May 3. Mol Cancer Ther. 2013. PMID: 23645591 Clinical Trial.

2

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, Kefford RF, Mann GJ. Holland EA, et al. Among authors: rizos h. Oncogene. 1995 Dec 7;11(11):2289-94. Oncogene. 1995. PMID: 8570179

3

Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.

Rizos H, Becker TM, Holland EA, Kefford RF, Mann GJ. Rizos H, et al. Oncogene. 1997 Jul 31;15(5):515-23. doi: 10.1038/sj.onc.1201217. Oncogene. 1997. PMID: 9247305

4

Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.

Rizos H, Darmanian AP, Indsto JO, Shannon JA, Kefford RF, Mann GJ. Rizos H, et al. Melanoma Res. 1999 Feb;9(1):10-9. doi: 10.1097/00008390-199902000-00003. Melanoma Res. 1999. PMID: 10338330

5

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

Rizos H, Darmanian AP, Mann GJ, Kefford RF. Rizos H, et al. Oncogene. 2000 Jun 15;19(26):2978-85. doi: 10.1038/sj.onc.1203629. Oncogene. 2000. PMID: 10871849

6

Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.

Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF. Rizos H, et al. J Biol Chem. 2001 Nov 2;276(44):41424-34. doi: 10.1074/jbc.M105299200. Epub 2001 Aug 22. J Biol Chem. 2001. PMID: 11518711 Free article.

7

A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.

Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Milà M, Kefford RF. Rizos H, et al. Oncogene. 2001 Sep 6;20(39):5543-7. doi: 10.1038/sj.onc.1204728. Oncogene. 2001. PMID: 11571653

8

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.

Becker TM, Rizos H, Kefford RF, Mann GJ. Becker TM, et al. Among authors: rizos h. Clin Cancer Res. 2001 Oct;7(10):3282-8. Clin Cancer Res. 2001. PMID: 11595726

9

Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition.

Rizos H, Diefenbach E, Badhwar P, Woodruff S, Becker TM, Rooney RJ, Kefford RF. Rizos H, et al. J Biol Chem. 2003 Feb 14;278(7):4981-9. doi: 10.1074/jbc.M210978200. Epub 2002 Nov 21. J Biol Chem. 2003. PMID: 12446718 Free article.

10

Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis.

Gallagher S, Kefford RF, Rizos H. Gallagher S, et al. Among authors: rizos h. Cell Cycle. 2005 Mar;4(3):465-72. doi: 10.4161/cc.4.3.1526. Epub 2005 Mar 7. Cell Cycle. 2005. PMID: 15701968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters